{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:32:49Z","timestamp":1774654369927,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.thromres.2013.05.023","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T04:23:39Z","timestamp":1372911819000},"page":"248-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A serendipitously identified novel small molecule procoagulant compound giving rise to a high-throughput screening assay based on human plasma"],"prefix":"10.1016","volume":"132","author":[{"given":"David","family":"Gustafsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofi","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"McPheat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"W\u00e5gberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Kaspersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Rohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Ulander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Fex","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Fjellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Deinum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2013.05.023_bb0005","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1365-2516.2009.02077.x","article-title":"Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens","volume":"15","author":"Berntorp","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2013.05.023_bb0010","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2141.2011.08765.x","article-title":"Haemophilia: Provision of factors and novel therapies: World Federation of Hemophilia goals and achievements","volume":"154","author":"Skinner","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2013.05.023_bb0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1515\/CCLM.2009.331","article-title":"Multiple gene interaction and modulation of hemostatic balance","volume":"47","author":"Franchini","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.thromres.2013.05.023_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1076029609351291","article-title":"Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease","volume":"16","author":"Ahmad","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0025","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","article-title":"Tranexamic acid: A review of its use in surgery and other Indications","volume":"57","author":"Dunn","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.thromres.2013.05.023_bb0030","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: The first 20years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.05.023_bb0035","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1055\/s-0038-1656992","article-title":"Thrombus weight as a measure of hypercoagulability induced by drugs","volume":"42","author":"MacIomhair","year":"1979","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1472-8206.2004.00256.x","article-title":"The hemostatic agent ethamsylate promotes platelet\/leukocyte aggregate formation in a model of vascular injury","volume":"18","author":"Hernandez","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.thromres.2013.05.023_bb0045","author":"National Institute for Health and Clinical Excellence"},{"key":"10.1016\/j.thromres.2013.05.023_bb0050","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1182\/blood-2012-03-306605","article-title":"Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation","volume":"119","author":"Morrissey","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.05.023_bb0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1538-7836.2009.03723.x","article-title":"Polyphosphate binds with high affinity to exosite II of thrombin","volume":"8","author":"Mutch","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1160\/TH05-05-0361","article-title":"Improved coagulation in bleeding disorders by non-anticoagulant sulfated polysaccharides (NASP)","volume":"95","author":"Liu","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood-2007-07-098913","article-title":"Efficacy and safety of a new class hemostatic drug candidate, AV513 in dogs with haemophilia A","volume":"111","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.05.023_bb0070","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1182\/blood-2010-10-311936","article-title":"Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor","volume":"117","author":"Waters","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2013.05.023_bb0075","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/j.1538-7836.2006.02226.x","article-title":"Peptidomimetic inhibitors for activated protein C: implications for hemophilia management","volume":"4","author":"Butenas","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0080","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1111\/j.1538-7836.2011.04504.x","article-title":"Activated protein C inhibitor for correction of thrombin generation in haemophilia A in blood and plasma","volume":"9","author":"Brummel-Ziedins","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0085","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1021\/jm0606950","article-title":"Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders","volume":"49","author":"De Nanteuil","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.thromres.2013.05.023_bb0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1432-1327.1998.2520553.x","article-title":"Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function","volume":"252","author":"Gal","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.thromres.2013.05.023_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2012.05.010","article-title":"Studies on the mechanism of action of the aptamer BAX499, an Inhibitor of tissue factor pathway inhibitor","volume":"130","author":"Chang","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2013.05.023_bb0100","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coph.2009.08.004","article-title":"Novel trends in high-throughput screening","volume":"9","author":"Mayr","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.thromres.2013.05.023_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.thromres.2013.05.023_bb0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1160\/TH04-10-0706","article-title":"Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B","volume":"93","author":"Dargaud","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0115","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's Disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2013.05.023_bb0120","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/j.1538-7836.2005.01363.x","article-title":"Molecular recognition mechanisms of thrombin","volume":"2","author":"Huntington","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bpc.2006.08.005","article-title":"Crystal structure of thrombin in complex with fibrinogen \u03b3\u00b4 peptide","volume":"125","author":"Pineda","year":"2007","journal-title":"Biophys Chem"},{"key":"10.1016\/j.thromres.2013.05.023_bb0130","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1074\/jbc.M707710200","article-title":"Bivalent binding to \u03b3A\/\u03b3\u00b4-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex","volume":"283","author":"Fredenburg","year":"2008","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.thromres.2013.05.023_bb0135","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1182\/blood-2005-05-2180","article-title":"Genetic variation in the fibrinogen gamma gene increases the risk of deep venous thrombosis by reducing plasma fibrinogen \u03b3\u00b4 levels","volume":"106","author":"Uitte de Willige","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2013.05.023_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1538-7836.2006.02270.x","article-title":"Plasma fibrinogen \u03b3\u2019 prime chain content in the thrombotic microangiopathy syndrome","volume":"5","author":"Mosesson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1160\/TH08-05-0275","article-title":"Heparin is procoagulant in the absence of antithrombin","volume":"100","author":"Smith","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2013.05.023_bb0150","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1021\/jm701583b","article-title":"Identification of promiscuous small molecule activators in high-throughput enzyme activation screens","volume":"51","author":"Goode","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.thromres.2013.05.023_bb0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1160\/TH04-03-0154","article-title":"Blood coagulation kinetics: high throughput method for real-time reaction monitoring","volume":"92","author":"Lo","year":"2004","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813002156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384813002156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T18:28:31Z","timestamp":1596047311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384813002156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0049384813002156"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2013.05.023","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A serendipitously identified novel small molecule procoagulant compound giving rise to a high-throughput screening assay based on human plasma","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2013.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}